Orin Hirschman 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-20 08:08 am Sale | 2023-03-16 | 13G | Paratek Pharmaceuticals, Inc. PRTK | Orin Hirschman | 2,802,115 4.900% | -1,354,776 (-32.59%) | Filing |
| 2023-02-15 07:18 am Purchase | 2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK | Orin Hirschman | 4,156,891 7.500% | 269,719 (+6.94%) | Filing |
| 2022-07-07 2:58 pm Purchase | 2022-07-05 | 13G | Paratek Pharmaceuticals, Inc. PRTK | Orin Hirschman | 3,887,172 7.700% | 1,067,105 (+37.84%) | Filing |
| 2022-03-09 08:10 am Purchase | 2022-02-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK | Orin Hirschman | 2,820,067 5.600% | 2,820,067 (New Position) | Filing |